Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

When looking at the problems plaguing American healthcare and the potential contributions of pharmacists to help improve patient outcomes, experts often repeat the same refrains: encourage better patient medication adherence; offe...

View Blog Post
Blog Post

Pressures to reduce opioid analgesic prescribing has resulted in an increased use of nonsteroidal anti-inflammatories and acetaminophen. With this uptick in use of over-the-counter ibuprofen and acetaminophen, the addition of caff...

View Blog Post
Blog Post

Since 2015, the healthcare industry has been tracking the progress and awaiting the wide-scale availability of biosimilars, a potentially more affordable ...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up